FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:541-549 February 24, 2000 Number 8 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Orthostatic intolerance is a syndrome characterized by lightheadedness, fatigue, altered mentation, and syncope and associated with postural tachycardia and plasma norepinephrine concentrations that are disproportionately high in relation to sympathetic outflow. We tested the hypothesis that impaired functioning of the norepinephrine transporter contributes to the pathophysiologic mechanism of orthostatic intolerance.

Methods In a patient with orthostatic intolerance and her relatives, we measured postural blood pressure, heart rate, plasma catecholamines, and systemic norepinephrine spillover and clearance, and we sequenced the norepinephrine-transporter gene and evaluated its function.

Results The patient had a high mean plasma norepinephrine concentration while standing, as compared with the mean (±SD) concentration in normal subjects (923 vs. 439±129 pg per milliliter [5.46 vs. 2.59±0.76 nmol per liter]), reduced systemic norepinephrine clearance (1.56 vs. 2.42±0.71 liters per minute), impairment in the increase in the plasma norepinephrine concentration after the administration of tyramine (12 vs. 56±63 pg per milliliter [0.07 vs. 0.33± 0.37 pmol per liter]), and a disproportionate increase in the concentration of plasma norepinephrine relative to that of dihydroxyphenylglycol. Analysis of the norepinephrine-transporter gene revealed that the proband was heterozygous for a mutation in exon 9 (encoding a change from guanine to cytosine at position 237) that resulted in more than a 98 percent loss of function as compared with that of the wild-type gene. Impairment of synaptic norepinephrine clearance may result in a syndrome characterized by excessive sympathetic activation in response to physiologic stimuli. The mutant allele in the proband's family segregated with the postural heart rate and abnormal plasma catecholamine homeostasis.

Conclusions Genetic or acquired deficits in norepinephrine inactivation may underlie hyperadrenergic states that lead to orthostatic intolerance.

Source Information

From the Autonomic Dysfunction Center (J.R.S., J.J., G.J., B.K.B., I.B., D.R.) and the Center for Molecular Neuroscience (N.L.F., R.D.B.), Departments of Medicine, Pharmacology, and Neurology, Vanderbilt University, Nashville.

Address reprint requests to Dr. Robertson at the General Clinical Research Center, AA3228 MCN, Vanderbilt University, Nashville, TN 37232-2195, or at david.robertson{at}mcmail.vanderbilt.edu.

Full Text of this Article

This article has been cited by other articles:

• Lambert, E., Eikelis, N., Esler, M., Dawood, T., Schlaich, M., Bayles, R., Socratous, F., Agrotis, A., Jennings, G., Lambert, G., Vaddadi, G. (2008). Altered Sympathetic Nervous Reactivity and Norepinephrine Transporter Expression in Patients With Postural Tachycardia Syndrome. Circ Arrhythmia Electrophysiol 1: 103-109 [Abstract] [Full Text]  
• Grubb, B. P. (2008). Postural Tachycardia Syndrome. Circulation 117: 2814-2817 [Full Text]  
• KIM, C.-H., WALDMAN, I. D., BLAKELY, R. D., KIM, K.-S. (2008). Functional Gene Variation in the Human Norepinephrine Transporter: Association with Attention Deficit Hyperactivity Disorder. Ann. N. Y. Acad. Sci. 1129: 256-260 [Abstract] [Full Text]  
• Moldovanova, I., Schroeder, C., Jacob, G., Hiemke, C., Diedrich, A., Luft, F. C., Jordan, J. (2008). Hormonal Influences on Cardiovascular Norepinephrine Transporter Responses in Healthy Women. Hypertension 51: 1203-1209 [Abstract] [Full Text]  
• Strempel, S., Schroeder, C., Hemmersbach, R., Boese, A., Tank, J., Diedrich, A., Heer, M., Luft, F. C., Jordan, J. (2008). Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation. J. Appl. Physiol. 104: 756-760 [Abstract] [Full Text]  
• Stewart, J. M., Taneja, I., Medow, M. S. (2007). Reduced central blood volume and cardiac output and increased vascular resistance during static handgrip exercise in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 293: H1908-H1917 [Abstract] [Full Text]  
• Garland, E. M., Raj, S. R., Black, B. K., Harris, P. A., Robertson, D. (2007). The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 69: 790-798 [Abstract] [Full Text]  
• Garland, E. M., Black, B. K., Harris, P. A., Robertson, D. (2007). Dopamine-beta-hydroxylase in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 293: H684-H690 [Abstract] [Full Text]  
• Heusser, K., Engeli, S., Tank, J., Diedrich, A., Wiesner, S., Janke, J., Luft, F. C., Jordan, J. (2007). Sympathetic Vasomotor Tone Determines Blood Pressure Response to Long-Term Sibutramine Treatment. J. Clin. Endocrinol. Metab. 92: 1560-1563 [Abstract] [Full Text]  
• Farhan, H., Reiterer, V., Korkhov, V. M., Schmid, J. A., Freissmuth, M., Sitte, H. H. (2007). Concentrative Export from the Endoplasmic Reticulum of the {gamma}-Aminobutyric Acid Transporter 1 Requires Binding to SEC24D. J. Biol. Chem. 282: 7679-7689 [Abstract] [Full Text]  
• McEvoy, M. D., Low, P. A., Hebbar, L. (2007). Postural Orthostatic Tachycardia Syndrome: Anesthetic Implications in the Obstetric Patient. Anesth. Analg. 104: 166-167 [Abstract] [Full Text]  
• Kim, C.-H., Hahn, M. K., Joung, Y., Anderson, S. L., Steele, A. H., Mazei-Robinson, M. S., Gizer, I., Teicher, M. H., Cohen, B. M., Robertson, D., Waldman, I. D., Blakely, R. D., Kim, K.-S. (2006). A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl. Acad. Sci. USA 103: 19164-19169 [Abstract] [Full Text]  
• Schroeder, C., Birkenfeld, A. L., Mayer, A. F., Tank, J., Diedrich, A., Luft, F. C., Jordan, J. (2006). Norepinephrine Transporter Inhibition Prevents Tilt-Induced Pre-Syncope. J Am Coll Cardiol 48: 516-522 [Abstract] [Full Text]  
• Corbett, W. L., Reiter, C. M., Schultz, J. R., Kanter, R. J., Habib, A. S. (2006). Anaesthetic management of a parturient with the postural orthostatic tachycardia syndrome: a case report. Br J Anaesth 97: 196-199 [Abstract] [Full Text]  
• Esler, M., Alvarenga, M., Pier, C., Richards, J., El-Osta, A., Barton, D., Haikerwal, D., Kaye, D., Schlaich, M., Guo, L., Jennings, G., Socratous, F., Lambert, G. (2006). The neuronal noradrenaline transporter, anxiety and cardiovascular disease.. J Psychopharmacol 20: 60-66 [Abstract]  
• Mayer, A. F., Schroeder, C., Heusser, K., Tank, J., Diedrich, A., Schmieder, R. E., Luft, F. C., Jordan, J. (2006). Influences of Norepinephrine Transporter Function on the Distribution of Sympathetic Activity in Humans. Hypertension 48: 120-126 [Abstract] [Full Text]  
• Jacob, G., Garland, E. M., Costa, F., Stein, C. M., Xie, H.-G., Robertson, R. M., Biaggioni, I., Robertson, D. (2006). {beta}2-Adrenoceptor Genotype and Function Affect Hemodynamic Profile Heterogeneity in Postural Tachycardia Syndrome. Hypertension 47: 421-427 [Abstract] [Full Text]  
• Alvarenga, M. E., Richards, J. C., Lambert, G., Esler, M. D. (2006). Psychophysiological Mechanisms in Panic Disorder: A Correlative Analysis of Noradrenaline Spillover, Neuronal Noradrenaline Reuptake, Power Spectral Analysis of Heart Rate Variability, and Psychological Variables. Psychosom. Med. 68: 8-16 [Abstract] [Full Text]  
• Garland, E. M., Winker, R., Williams, S. M., Jiang, L., Stanton, K., Byrne, D. W., Biaggioni, I., Cascorbi, I., Phillips, J. A. III, Harris, P. A., Rudiger, H., Robertson, D. (2005). Endothelial NO Synthase Polymorphisms and Postural Tachycardia Syndrome. Hypertension 46: 1103-1110 [Abstract] [Full Text]  
• Schondorf, R., Benoit, J., Stein, R. (2005). Cerebral autoregulation is preserved in postural tachycardia syndrome. J. Appl. Physiol. 99: 828-835 [Abstract] [Full Text]  
• Muenter Swift, N., Charkoudian, N., Dotson, R. M., Suarez, G. A., Low, P. A. (2005). Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 289: H1226-H1233 [Abstract] [Full Text]  
• Prasad, H. C., Zhu, C.-B., McCauley, J. L., Samuvel, D. J., Ramamoorthy, S., Shelton, R. C., Hewlett, W. A., Sutcliffe, J. S., Blakely, R. D. (2005). Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 102: 11545-11550 [Abstract] [Full Text]  
• Hahn, M. K., Mazei-Robison, M. S., Blakely, R. D. (2005). Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation. Mol. Pharmacol. 68: 457-466 [Abstract] [Full Text]  
• Ruoho, A. E. (2005). How the Monoamine Transporter Garden Grows. Mol. Pharmacol. 68: 272-274 [Abstract] [Full Text]  
• Grubb, B. P. (2005). Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance. Circulation 111: 2997-3006 [Full Text]  
• Schwartz, J. W., Novarino, G., Piston, D. W., DeFelice, L. J. (2005). Substrate Binding Stoichiometry and Kinetics of the Norepinephrine Transporter. J. Biol. Chem. 280: 19177-19184 [Abstract] [Full Text]  
• Raj, S. R., Biaggioni, I., Yamhure, P. C., Black, B. K., Paranjape, S. Y., Byrne, D. W., Robertson, D. (2005). Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome. Circulation 111: 1574-1582 [Abstract] [Full Text]  
• Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., Nielsen, D. A. (2005). Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments. Pharmacol. Rev. 57: 1-26 [Abstract] [Full Text]  
• Winker, R., Barth, A., Bidmon, D., Ponocny, I., Weber, M., Mayr, O., Robertson, D., Diedrich, A., Maier, R., Pilger, A., Haber, P., Rudiger, H. W. (2005). Endurance Exercise Training in Orthostatic Intolerance: A Randomized, Controlled Trial. Hypertension 45: 391-398 [Abstract] [Full Text]  
• Goldstein, D. S., Eldadah, B., Holmes, C., Pechnik, S., Moak, J., Sharabi, Y. (2005). Neurocirculatory Abnormalities in Chronic Orthostatic Intolerance. Circulation 111: 839-845 [Abstract] [Full Text]  
• Márquez, M. F., Urias, K. I., Hermosillo, A. G., Jardón, J. L., Iturralde, P., Colín, L., Nava, S., Cárdenas, M. (2005). Familial vasovagal syncope. Europace 7: 472-474 [Abstract] [Full Text]  
• Seidel, S., Singer, E. A., Just, H., Farhan, H., Scholze, P., Kudlacek, O., Holy, M., Koppatz, K., Krivanek, P., Freissmuth, M., Sitte, H. H. (2005). Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action. Mol. Pharmacol. 67: 140-151 [Abstract] [Full Text]  
• Bonyhay, I., Freeman, R. (2004). Sympathetic Nerve Activity in Response to Hypotensive Stress in the Postural Tachycardia Syndrome. Circulation 110: 3193-3198 [Abstract] [Full Text]  
• Tsapakis, E. M., Basu, A., Aitchison, K. J. (2004). Clinical relevance of discoveries in psychopharmacogenetics. Adv. Psychiatr. Treat. 10: 455-465 [Abstract] [Full Text]  
• Keller, N. R., Diedrich, A., Appalsamy, M., Tuntrakool, S., Lonce, S., Finney, C., Caron, M. G., Robertson, D. (2004). Norepinephrine Transporter-Deficient Mice Exhibit Excessive Tachycardia and Elevated Blood Pressure With Wakefulness and Activity. Circulation 110: 1191-1196 [Abstract] [Full Text]  
• Eisenhofer, G., Kopin, I. J., Goldstein, D. S. (2004). Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine. Pharmacol. Rev. 56: 331-349 [Abstract] [Full Text]  
• Vincent, S., Bieck, P. R., Garland, E. M., Loghin, C., Bymaster, F. P., Black, B. K., Gonzales, C., Potter, W. Z., Robertson, D. (2004). Clinical Assessment of Norepinephrine Transporter Blockade Through Biochemical and Pharmacological Profiles. Circulation 109: 3202-3207 [Abstract] [Full Text]  
• GOLDSTEIN, D. S. (2004). Functional Neuroimaging of Sympathetic Innervation of the Heart. Ann. N. Y. Acad. Sci. 1018: 231-243 [Abstract] [Full Text]  
• Kim, H J, Camilleri, M, Carlson, P J, Cremonini, F, Ferber, I, Stephens, D, McKinzie, S, Zinsmeister, A R, Urrutia, R (2004). Association of distinct {alpha}2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53: 829-837 [Abstract] [Full Text]  
• Kawada, T., Miyamoto, T., Uemura, K., Kashihara, K., Kamiya, A., Sugimachi, M., Sunagawa, K. (2004). Effects of neuronal norepinephrine uptake blockade on baroreflex neural and peripheral arc transfer characteristics. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286: R1110-R1120 [Abstract] [Full Text]  
• Schroeder, C., Adams, F., Boschmann, M., Tank, J., Haertter, S., Diedrich, A., Biaggioni, I., Luft, F. C., Jordan, J. (2004). Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286: R851-R856 [Abstract] [Full Text]  
• Jayanthi, L. D., Samuvel, D. J., Ramamoorthy, S. (2004). Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters: EVIDENCE FOR LOCALIZATION IN LIPID RAFTS AND LIPID RAFT-MEDIATED INTERNALIZATION. J. Biol. Chem. 279: 19315-19326 [Abstract] [Full Text]  
• Murphy, D. L., Lerner, A., Rudnick, G., Lesch, K.-P. (2004). Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics. Mol. Interv. 4: 109-123 [Abstract] [Full Text]  
• Robinson, M. B. (2003). Signaling Pathways Take Aim at Neurotransmitter Transporters. Sci Signal 2003: pe50-pe50 [Abstract] [Full Text]  
• Sharpe, I. A., Palant, E., Schroeder, C. I., Kaye, D. M., Adams, D. J., Alewood, P. F., Lewis, R. J. (2003). Inhibition of the Norepinephrine Transporter by the Venom Peptide {chi}-MrIA: SITE OF ACTION, Na+ DEPENDENCE, AND STRUCTURE-ACTIVITY RELATIONSHIP. J. Biol. Chem. 278: 40317-40323 [Abstract] [Full Text]  
• Horvath, G., Sutto, Z., Torbati, A., Conner, G. E., Salathe, M., Wanner, A. (2003). Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L829-L837 [Abstract] [Full Text]  
• Rasmussen, L. E., Nedergaard, O. A. (2003). Effects of Reboxetine on Sympathetic Neuroeffector Transmission in Rabbit Carotid Artery. J. Pharmacol. Exp. Ther. 306: 995-1002 [Abstract] [Full Text]  
• Tank, J., Schroeder, C., Diedrich, A., Szczech, E., Haertter, S., Sharma, A. M., Luft, F. C., Jordan, J. (2003). Selective Impairment in Sympathetic Vasomotor Control With Norepinephrine Transporter Inhibition. Circulation 107: 2949-2954 [Abstract] [Full Text]  
• Yusuf, S., Camm, A. J. (2003). Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven?. J CARDIOVASC PHARMACOL THER 8: 89-105 [Abstract]  
• Hahn, M. K., Robertson, D., Blakely, R. D. (2003). A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters. J. Neurosci. 23: 4470-4478 [Abstract] [Full Text]  
• Van Lieshout, J. J., Wieling, W., Karemaker, J. M., Secher, N. H. (2003). Syncope, cerebral perfusion, and oxygenation. J. Appl. Physiol. 94: 833-848 [Abstract] [Full Text]  
• Sung, U., Apparsundaram, S., Galli, A., Kahlig, K. M., Savchenko, V., Schroeter, S., Quick, M. W., Blakely, R. D. (2003). A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity. J. Neurosci. 23: 1697-1709 [Abstract] [Full Text]  
• Horvath, G., Torbati, A., Conner, G. E., Salathe, M., Wanner, A. (2002). Systemic Ovalbumin Sensitization Downregulates Norepinephrine Uptake by Rabbit Aortic Smooth Muscle Cells. Am. J. Respir. Cell Mol. Bio. 27: 746-751 [Abstract] [Full Text]  
• Carson, R. P., Diedrich, A., Robertson, D. (2002). Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance. J. Appl. Physiol. 93: 2192-2198 [Abstract] [Full Text]  
• Goldstein, D. S., Robertson, D., Esler, M., Straus, S. E., Eisenhofer, G. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. ANN INTERN MED 137: 753-763 [Abstract] [Full Text]  
• Birkenfeld, A. L., Schroeder, C., Boschmann, M., Tank, J., Franke, G., Luft, F. C., Biaggioni, I., Sharma, A. M., Jordan, J. (2002). Paradoxical Effect of Sibutramine on Autonomic Cardiovascular Regulation. Circulation 106: 2459-2465 [Abstract] [Full Text]  
• Boschmann, M., Schroeder, C., Christensen, N. J., Tank, J., Krupp, G., Biaggioni, I., Klaus, S., Sharma, A. M., Luft, F. C., Jordan, J. (2002). Norepinephrine Transporter Function and Autonomic Control of Metabolism. J. Clin. Endocrinol. Metab. 87: 5130-5137 [Abstract] [Full Text]  
• Khan, M. H., Sinoway, L. I., MacLean, D. A. (2002). Effects of graded LBNP on MSNA and interstitial norepinephrine. Am. J. Physiol. Heart Circ. Physiol. 283: H2038-H2044 [Abstract] [Full Text]  
• Goldstein, D. S., Holmes, C., Frank, S. M., Dendi, R., Cannon, R. O. III, Sharabi, Y., Esler, M. D., Eisenhofer, G. (2002). Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes. Circulation 106: 2358-2365 [Abstract] [Full Text]  
• PARMER, R. J., ZINDER, O. (2002). Catecholaminergic Pathways, Chromaffin Cells, and Human Disease. Ann. N. Y. Acad. Sci. 971: 497-505 [Abstract] [Full Text]  
• GARLAND, E. M., HAHN, M. K., KETCH, T. P., KELLER, N. R., KIM, C.-H., KIM, K.-S., BIAGGIONI, I., SHANNON, J. R., BLAKELY, R. D., ROBERTSON, D. (2002). Genetic Basis of Clinical Catecholamine Disorders. Ann. N. Y. Acad. Sci. 971: 506-514 [Abstract] [Full Text]  
• Freeman, R., Lirofonis, V., Farquhar, W. B., Risk, M. (2002). Limb venous compliance in patients with idiopathic orthostatic intolerance and postural tachycardia. J. Appl. Physiol. 93: 636-644 [Abstract] [Full Text]  
• Janssen, B. J. A., Smits, J. F. M. (2002). Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R1545-R1564 [Abstract] [Full Text]  
• Carson, R. P., Robertson, D. (2002). Genetic Manipulation of Noradrenergic Neurons. J. Pharmacol. Exp. Ther. 301: 410-417 [Abstract] [Full Text]  
• Kim, C.-H., Hwang, D.-Y., Park, J.-J., Kim, K.-S. (2002). A Proximal Promoter Domain Containing a Homeodomain-Binding Core Motif Interacts with Multiple Transcription Factors, Including HoxA5 and Phox2 Proteins, and Critically Regulates Cell Type-Specific Transcription of the Human Norepinephrine Transporter Gene. J. Neurosci. 22: 2579-2589 [Abstract] [Full Text]  
• Cabassi, A., Vinci, S., Cantoni, A. M., Quartieri, F., Moschini, L., Cavazzini, S., Cavatorta, A., Borghetti, A. (2002). Sympathetic Activation in Adipose Tissue and Skeletal Muscle of Hypertensive Rats. Hypertension 39: 656-661 [Abstract] [Full Text]  
• Schroeder, C., Tank, J., Boschmann, M., Diedrich, A., Sharma, A. M., Biaggioni, I., Luft, F. C., Jordan, J. (2002). Selective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance. Circulation 105: 347-353 [Abstract] [Full Text]  
• Jordan, J., Shannon, J. R., Diedrich, A., Black, B. K., Robertson, D. (2002). Increased Sympathetic Activation in Idiopathic Orthostatic Intolerance: Role of Systemic Adrenoreceptor Sensitivity. Hypertension 39: 173-178 [Abstract] [Full Text]  
• Apparsundaram, S., Sung, U., Price, R. D., Blakely, R. D. (2001). Trafficking-Dependent and -Independent Pathways of Neurotransmitter Transporter Regulation Differentially Involving p38 Mitogen-Activated Protein Kinase Revealed in Studies of Insulin Modulation of Norepinephrine Transport in SK-N-SH Cells. J. Pharmacol. Exp. Ther. 299: 666-677 [Abstract] [Full Text]  
• Blakely, R. D. (2001). Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind. J. Neurosci. 21: 8319-8323 [Abstract] [Full Text]  
• Zwart, R., Verhaagh, S., Buitelaar, M., Popp-Snijders, C., Barlow, D. P. (2001). Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 in Orct3/Slc22a3-Deficient Mice. Mol. Cell. Biol. 21: 4188-4196 [Abstract] [Full Text]  
• SCHONDORF, R., BENOIT, J., STEIN, R. (2001). Cerebral Autoregulation in Orthostatic Intolerance. Ann. N. Y. Acad. Sci. 940: 514-526 [Abstract] [Full Text]  
• ROBERTSON, D., FLATTEM, N., TELLIOGLU, T., CARSON, R., GARLAND, E., SHANNON, J. R., JORDAN, J., JACOB, G., BLAKELY, R. D., BIAGGIONI, I. (2001). Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency. Ann. N. Y. Acad. Sci. 940: 527-544 [Abstract] [Full Text]  
• Carson, R. P., Appalsamy, M., Diedrich, A., Davis, T. L., Robertson, D. (2001). Animal Model of Neuropathic Tachycardia Syndrome. Hypertension 37: 1357-1361 [Abstract] [Full Text]  
• Cabassi, A., Vinci, S., Quartieri, F., Moschini, L., Borghetti, A. (2001). Norepinephrine Reuptake Is Impaired in Skeletal Muscle of Hypertensive Rats In Vivo. Hypertension 37: 698-702 [Abstract] [Full Text]  
• Rumantir, M. S., Kaye, D. M., Jennings, G. L., Vaz, M., Hastings, J. A., Esler, M. D. (2000). Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension. Hypertension 36: 824-829 [Abstract] [Full Text]  
• Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan, R. A., Blakely, R. D. (2000). Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A. J. Neurosci. 20: 7571-7578 [Abstract] [Full Text]  
• Jacob, G., Costa, F., Shannon, J. R., Robertson, R. M., Wathen, M., Stein, M., Biaggioni, I., Ertl, A., Black, B., Robertson, D. (2000). The Neuropathic Postural Tachycardia Syndrome. NEJM 343: 1008-1014 [Abstract] [Full Text]  
• (2000). Genetic Basis for Orthostatic Intolerance. Journal Watch Cardiology 2000: 6-6 [Full Text]  
• Kim, C.-H., Ardayfio, P., Kim, K.-S. (2001). An E-box Motif Residing in the Exon/Intron 1 Junction Regulates Both Transcriptional Activation and Splicing of the Human Norepinephrine Transporter Gene. J. Biol. Chem. 276: 24797-24805 [Abstract] [Full Text]  
• Holschneider, D. P., Scremin, O. U., Roos, K. P., Chialvo, D. R., Chen, K., Shih, J. C. (2002). Increased baroreceptor response in mice deficient in monoamine oxidase A and B. Am. J. Physiol. Heart Circ. Physiol. 282: H964-H972 [Abstract] [Full Text]